Showing 21 - 40 results of 112 for search '"lung transplant"', query time: 0.10s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26

    Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient by Kelly E. Schoeppler, Martin R. Zamora, Noelle M. Northcutt, Gerard R. Barber, Gayle O’Malley-Schroeder, Dennis M. Lyu

    Published 2015-01-01
    “…Here we present a rare case of invasive infection caused by Microascus trigonosporus species complex in a human, which developed during voriconazole prophylaxis in a lung transplant recipient. Nebulized liposomal amphotericin B was used in addition to systemic therapy in order to optimize antifungal drug exposure; this regimen appeared to reduce the patient’s fungal burden. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29

    Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient by Heinrike Wilkens, Martina Sester

    Published 2016-01-01
    “…Cytomegalovirus (CMV) infection after lung transplantation is associated with increased risk for pneumonitis and bronchiolitis obliterans as well as allograft rejection and opportunistic infections. …”
    Get full text
    Article
  10. 30

    Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation by Junko Tokuno, Toyofumi F Chen-Yoshikawa, Toru Oga, Takahiro Oto, Tomoyo Okawa, Yoshinori Okada, Miki Akiba, Masaki Ikeda, Daisuke Nakajima, Masatsugu Hamaji, Hideki Motoyama, Akihiro Aoyama, Maki Isomi, Kazuo Chin, Hiroshi Date

    Published 2020-01-01
    “…Improving health-related quality of life (HRQL) is an important goal of lung transplantation, and St. George’s Respiratory Questionnaire (SGRQ) is frequently used for assessing HRQL in patients waitlisted for lung transplantation. …”
    Get full text
    Article
  11. 31
  12. 32

    Continuous Erector Spinae Plane Block for Analgesia after Thoracotomy for Lung Transplantation in an Anticoagulated Patient by Mark Mudarth, Veena Satyapriya, John Coffman, Peter DeSocio, Alec Lawrence, Shana Schwartz, Michael Kushelev

    Published 2021-01-01
    “…Lung transplant recipients are at particular high risk for postoperative respiratory failure as a result of poorly controlled pain, inadequate graft expansion, decreased cough, and reliance on systemic opioid therapy. …”
    Get full text
    Article
  13. 33

    Pre-Anesthesia Extracorporeal Membrane Oxygenation in Two Lung Transplant Recipients with Severe Pulmonary Hypertension by Liu Minqiang, Gao Hong, Chen Jingyu, Wang Yanjuan, Xu Bo, Wang Guilong, Wu Qiang, Hu Chunxiao

    Published 2020-01-01
    “…Extracorporeal membrane oxygenation (ECMO) is a widely used cardiopulmonary support method that is usually implemented after anesthesia during the period of lung transplantation (LTx). In severe pulmonary arterial hypertension (PAH) patients, however, anesthesia induction is a high-risk phase and can result in severe cardiorespiratory failure. …”
    Get full text
    Article
  14. 34

    Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation by Esmaeil Mortaz, Saeede Amani, Sharon Mumby, Ian M. Adcock, Mehrnaz Movassaghi, Jelle Folkerts, Johan Garssen, Gert Folkerts

    Published 2018-01-01
    “…This paper outlines the current understanding of the role of MCs in lung transplantation, with a specific focus on their interaction with ILC2 cells within the engrafted organ.…”
    Get full text
    Article
  15. 35
  16. 36

    Burkholderia Gladioli – A Predictor of Poor Outcome in Cystic Fibrosis Patients Who Receive Lung Transplants? A Case of Locally Invasive Rhinosinusitis and Persistent Bacteremia in a 36-Year-Old Lung Transplant Recipient with Cystic Fibrosis by Bradley S Quon, James D Reid, Patrick Wong, Pearce G Wilcox, Amin Javer, Jennifer M Wilson, Robert D Levy

    Published 2011-01-01
    “…A case involving a lung transplant recipient with cystic fibrosis who ultimately died as a result of severe rhinosinusitis due to B gladioli infection in the context of postlung transplant immunosuppression is reported.…”
    Get full text
    Article
  17. 37

    Respiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient by Nathan C. Bahr, Katherine Janssen, Joanne Billings, Gabriel Loor, Jaime S. Green

    Published 2015-01-01
    “…We believe that this was likely a donor-derived infection given the early timing of the Sporothrix isolation after transplant in a bilateral single lung transplant recipient. This is the first case report of sporotrichosis in a lung transplant recipient. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40

    Health-related Quality of Life and Exercise Capacity in Double Lung Transplant Recipients With Baseline Lung Allograft Dysfunction by Alisha Rullay, BSc, Karina Kaur, BSc, Jennifer Holman, PT, Laura C. van den Bosch, MD, Justin G. Weinkauf, MD, Jayan Nagendran, MD, PhD, Rhea A. Varughese, MD, Alim S. Hirji, MD, Dale C. Lien, MD, Jason C. Weatherald, MD, Kieran M. Halloran, MD

    Published 2025-02-01
    “…We hypothesized that BLAD would be associated with reduced HRQL and 6-min walk distance (6MWD) at 1 y post–lung transplant. Methods. We analyzed patients who underwent lung transplants in our program from 2004 to 2018 who completed 1-y 36-item Short Form (SF-36) questionnaire and 6MWD testing. …”
    Get full text
    Article